Joaquin Mould-Quevedo
17PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (17)
Sort by Publication Date:
|Mar 27, 2026
Cost-Effectiveness and Budget Impact Analysis of the Trivalent Adjuvanted Influenza Vaccine in People over 50 Years of Age for Argentina.Leandro Javier Pastori, Constanza Silvestrini Viola, Tomas Alconada
|Apr 23, 2025
Cost-Effectiveness of Adjuvanted Influenza Vaccine Compared with Standard and High-Dose Influenza Vaccines for Persons Aged ≥50 Years in Spain.Alberto Perez-Rubio, Roberto Flores, Jesus Ruiz Aragon
|Dec 27, 2024
Absenteeism and Productivity Loss Due to Influenza or Influenza-like Illness in Adults in Europe and North America.David Fisman, Maarten Postma, Myron J Levin
|Nov 26, 2024
A Clinical and Economic Comparison of Cell-Based Versus Recombinant Influenza Vaccines in Adults 18-64 Years in the United States.Myron J Levin, Neda Al Rawashdh, Liliane Mofor
|Oct 26, 2024
Modelling the Relative Vaccine Efficacy of ARCT-154, a Self-Amplifying mRNA COVID-19 Vaccine, versus BNT162b2 Using Immunogenicity Data.Van Hung Nguyen, Pascal Crépey, Jean Marie Pivette
|Jun 27, 2024
Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France.Marc Paccalin, Gaëtan Gavazzi, Quentin Berkovitch
Pageof 3
Frequent Collaborators
2 joint publications
Sergio Márquez-Peláez
1 joint publications
Joon Young Song
1 joint publications
Chia-Yu Chi
1 joint publications
Ming-Fang Cheng
1 joint publications
Karam Ko
1 joint publications
Chih-Jung Chen
1 joint publications
Yhu-Chering Huang
1 joint publications
Ping-Ing Lee
1 joint publications
Marc Paccalin
1 joint publications
Nansa Burlet
